Vera Therapeutics, Inc.
US ˙ NasdaqGM ˙ US92337R1014

SecurityVERA / Vera Therapeutics, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Ownership 0.10%
Citadel Advisors Llc ownership in VERA / Vera Therapeutics, Inc.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (VERA) in the form of stock options. The firm currently holds call options representing 94,800 of underlying shares valued at $3,813,804 USD and put options representing 17,400 of underlying shares valued at $700,002 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2024-02-14 2024-02-14 13G/A 0.10 -98.61
2023-02-14 2023-02-14 13G/A 7.20 -25.00
2022-02-14 2022-02-14 13G/A 9.60 -3.03
2021-05-28 2021-05-28 13G 9.90

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

VERA / Vera Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VERA THERAPEUTICS CL A 92337R101 429,761 -347,727 -44.72 17,289 -56.09 0.0025
2026-02-17 2025-12-31 13F VERA THERAPEUTICS CL A 92337R101 777,488 -837,850 -51.87 39,372 -16.13 0.0059
2025-11-14 2025-09-30 13F VERA THERAPEUTICS CL A 92337R101 1,615,338 1,052,472 186.98 46,942 253.98 0.0071
2025-08-14 2025-06-30 13F VERA THERAPEUTICS CL A 92337R101 562,866 351,071 165.76 13,261 160.68 0.0023
2025-05-15 2025-03-31 13F VERA THERAPEUTICS CL A 92337R101 211,795 156,989 286.44 5,087 119.55 0.0010
2025-02-14 2024-12-31 13F VERA THERAPEUTICS CL A 92337R101 54,806 51,736 1,685.21 2,318 1,616.30 0.0004
2024-11-14 2024-09-30 13F VERA THERAPEUTICS CL A 92337R101 3,070 -1,581 -33.99 136 -19.64 0.0000
2024-08-14 2024-06-30 13F VERA THERAPEUTICS CL A 92337R101 4,651 -22,311 -82.75 168 -85.54 0.0000
2024-05-15 2024-03-31 13F VERA THERAPEUTICS CL A 92337R101 26,962 -12,685 -31.99 1,163 90.80 0.0002
2024-02-14 2023-12-31 13F VERA THERAPEUTICS CL A 92337R101 39,647 -4,647 -10.49 610 0.33 0.0001
2023-11-14 2023-09-30 13F VERA THERAPEUTICS CL A 92337R101 44,294 44,294 607 0.0001
2023-08-14 2023-06-30 13F VERA THERAPEUTICS CL A 92337R101 0 -775,792 -100.00 0 -100.00
2023-05-15 2023-03-31 13F VERA THERAPEUTICS CL A 92337R101 775,792 -1,215,681 -61.04 6,020 -84.38 0.0013
2023-02-14 2022-12-31 13F VERA THERAPEUTICS CL A 92337R101 1,991,473 0 0.00 38,535 -9.20 0.0090
2022-11-14 2022-09-30 13F VERA THERAPEUTICS CL A 92337R101 1,991,473 -131,378 -6.19 42,438 46.88 0.0097
2022-08-15 2022-06-30 13F VERA THERAPEUTICS CL A 92337R101 2,122,851 33,331 1.60 28,892 -41.14 0.0074
2022-05-16 2022-03-31 13F VERA THERAPEUTICS CL A 92337R101 2,089,520 356,338 20.56 49,083 5.99 0.0101
2022-02-14 2021-12-31 13F VERA THERAPEUTICS CL A 92337R101 1,733,182 4,834 0.28 46,311 59.20 0.0095
2021-11-15 2021-09-30 13F VERA THERAPEUTICS Cmn 92337R101 1,728,348 -10,345 -0.59 29,090 31.21 0.0060
2021-08-16 2021-06-30 13F VERA THERAPEUTICS CL A 92337R101 1,738,693 1,738,693 22,170 0.0050
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F VERA THERAPEUTICS CL A Call 94,800 66.90 3,814 32.58 n/a n/a n/a
2026-02-17 2025-12-31 13F VERA THERAPEUTICS CL A Call 56,800 276.16 2,876 556.62 n/a n/a n/a
2025-11-14 2025-09-30 13F VERA THERAPEUTICS CL A Call 15,100 -62.53 439 -53.85 n/a n/a n/a
2025-08-14 2025-06-30 13F VERA THERAPEUTICS CL A Call 40,300 75.22 949 71.92 n/a n/a n/a
2025-05-15 2025-03-31 13F VERA THERAPEUTICS CL A Call 23,000 219.44 552 81.58 n/a n/a n/a
2025-02-14 2024-12-31 13F VERA THERAPEUTICS CL A Call 7,200 16.13 304 10.95 n/a n/a n/a
2024-11-14 2024-09-30 13F VERA THERAPEUTICS CL A Call 6,200 158.33 274 218.60 n/a n/a n/a
2024-08-14 2024-06-30 13F VERA THERAPEUTICS CL A Call 2,400 -71.08 87 -75.91 n/a n/a n/a
2024-05-15 2024-03-31 13F VERA THERAPEUTICS CL A Call 8,300 118.42 358 515.52 n/a n/a n/a
2024-02-14 2023-12-31 13F VERA THERAPEUTICS CL A Call 3,800 -62.38 58 -57.97 n/a n/a n/a
2023-11-14 2023-09-30 13F VERA THERAPEUTICS CL A Call 10,100 -34.84 138 -44.35 n/a n/a n/a
2023-08-14 2023-06-30 13F VERA THERAPEUTICS CL A Call 15,500 158.33 249 439.13 n/a n/a n/a
2023-05-15 2023-03-31 13F VERA THERAPEUTICS CL A Call 6,000 47 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F VERA THERAPEUTICS CL A Put 17,400 10.13 700 -12.50 n/a n/a n/a
2026-02-17 2025-12-31 13F VERA THERAPEUTICS CL A Put 15,800 9.72 800 91.39 n/a n/a n/a
2025-11-14 2025-09-30 13F VERA THERAPEUTICS CL A Put 14,400 -81.47 418 -77.16 n/a n/a n/a
2025-08-14 2025-06-30 13F VERA THERAPEUTICS CL A Put 77,700 763.33 1,831 747.22 n/a n/a n/a
2025-05-15 2025-03-31 13F VERA THERAPEUTICS CL A Put 9,000 -69.70 216 -82.80 n/a n/a n/a
2025-02-14 2024-12-31 13F VERA THERAPEUTICS CL A Put 29,700 6.45 1,256 1.87 n/a n/a n/a
2024-11-14 2024-09-30 13F VERA THERAPEUTICS CL A Put 27,900 -13.62 1,233 5.57 n/a n/a n/a
2024-08-14 2024-06-30 13F VERA THERAPEUTICS CL A Put 32,300 -44.02 1,169 -53.05 n/a n/a n/a
2024-05-15 2024-03-31 13F VERA THERAPEUTICS CL A Put 57,700 2,785.00 2,488 8,193.33 n/a n/a n/a
2024-02-14 2023-12-31 13F VERA THERAPEUTICS CL A Put 2,000 31 n/a n/a n/a
2023-11-14 2023-09-30 13F VERA THERAPEUTICS CL A Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-14 2023-06-30 13F VERA THERAPEUTICS CL A Put 10,400 477.78 167 1,176.92 n/a n/a n/a
2023-05-15 2023-03-31 13F VERA THERAPEUTICS CL A Put 1,800 14 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.